Search - tctmd.com

Presenter: Antonio J. Mu?oz-Garc?a, Jose M Hern?ndez Garc?a, Juan H. Alonso Briales, Manuel F. Jim?nez Navarro, Antonio J. Dom?nguez Franco, Maria J. Molina Mora, Isabel Rodr?guez Bailon, MIguel Such Mart?nez, Eduardo de Teresa Galv?n

January 03, 2012

News Daily News

Studies Show Valve-in-Valve TAVR Successful for Failed Surgical Bioprostheses

L.A. McKeown

December 29, 2011

News Daily News

Repositionable Valve Yields Promising 2-Year TAVR Results

December 06, 2011

News Conference News

TAVR: Incorporating Techniques into Daily Practice

November 07, 2011

News Conference News

TAVR Bioprosthesis Safe, Effective at 1 Year

November 07, 2011

News Daily News

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Jason Kahn

November 06, 2011

News Daily News

Patient-Prosthesis Mismatch May Diminish Transcatheter Valve Benefit

October 05, 2011

News Daily News

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

October 03, 2011

News Industry News

JenaValve Technology is first in receiving CE certification for a True Second-Generation Transapical TAVI System

September 30, 2011

News Daily News

TAVI Appears Safe for Patients with Small Annuli

August 22, 2011

News Daily News

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

May 09, 2011

Advertisement

Study Investigates Impact of Moderate or Severe MR in TAVR Patients

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

Hemodynamic Index Helps Define Impact of Aortic Regurgitation After TAVR

El Índice Hemodinámico Ayuda a Definir el Impacto de la Regurgitación Aórtica Tras la TAVR

TCTMD’s Top 10 Most Popular News Stories From 2011

Study Focuses on Systemic Inflammation After TAVR

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Percutaneous Valve Replacement Stakes Out the Tricuspid

Impact on the need for permanent pacemaker requirement after CoreValve prosthesis implantation with the new Accutrak delivery Catheter System

Studies Show Valve-in-Valve TAVR Successful for Failed Surgical Bioprostheses

Repositionable Valve Yields Promising 2-Year TAVR Results

TAVR: Incorporating Techniques into Daily Practice

TAVR Bioprosthesis Safe, Effective at 1 Year

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Patient-Prosthesis Mismatch May Diminish Transcatheter Valve Benefit

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

JenaValve Technology is first in receiving CE certification for a True Second-Generation Transapical TAVI System

TAVI Appears Safe for Patients with Small Annuli

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content